Sign inCreate account

Report workspace tools

NCT05366621COMPLETEDanonymous

The Association Between Anti-osteoporosis Medications and Lowered All Cause Mortality After Osteoporotic Fractures

Sponsor

Source record

National Cheng-Kung University Hospital

Phase

Source record

Completed

Modality

AI-normalized

monoclonal antibody

Target

AI-normalized

Osteoporosis and Mortality

Indication / condition

AI-normalized

Osteoporosis

Intervention

Source record

Anti-osteoporosis medications

Source & freshness

Source record

NCT ID

NCT05366621

Original source

ClinicalTrials.gov

Source last updated

Apr 04, 2023

Ingested at

May 30, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT05366621

Title

The Association Between Anti-osteoporosis Medications and Lowered All Cause Mortality After Osteoporotic Fractures

Sponsor

National Cheng-Kung University Hospital

Status

COMPLETED

Phase

Completed

Condition raw

Osteoporosis

Condition normalized

Osteoporosis

Modality raw

Osteoporosis

Modality normalized

monoclonal antibody

Target raw

Osteoporosis and Mortality

Target normalized

Osteoporosis and Mortality

Interventions

Anti-osteoporosis medications

Public preview

Source record

This observational study aimed to assess the relationship between anti-osteoporosis medications and all-cause mortality in older adults following osteoporotic fractures. Conducted by National Cheng-Kung University Hospital, it involved a cohort of 216,155 participants and spanned a 12-year observation period.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

The Association Between Anti-osteoporosis Medications and Lowered All Cause Mortality After Osteoporotic Fractures

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT05366621

Status

COMPLETED

Phase

Completed

Sponsor

National Cheng-Kung University Hospital

Executive brief

Investment-Ready Snapshot

This observational study aimed to assess the relationship between anti-osteoporosis medications and all-cause mortality in older adults following osteoporotic fractures. Conducted by National Cheng-Kung University Hospital, it involved a cohort of 216,155 participants and spanned a 12-year observation period.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedApr 04, 2023
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT05366621

Indication

Osteoporosis

Modality

monoclonal antibody

Target

Osteoporosis and Mortality

Intervention

Anti-osteoporosis medications

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.